OurMind

Founders and Team

OurMind was founded in 2024 by a team including Paul Koning, MD, a former orthopedic surgeon with a prior exit (Prisma Network, acquired by Doctolib), alongside co-founders Marco Ferraz, Fredrik Gustafsson, and Renan Sales Barros. The team combines clinical domain expertise with AI engineering capabilities [PERPLEXITY SONAR PRO BRIEF].

Links

• Website: https://www.ourmind.ai/
• LinkedIn: https://www.linkedin.com/company/ourmind-ai/

Executive Summary

OurMind is an Amsterdam-based healthtech startup building an AI platform to automate clinical documentation. The company has secured €2.1 million in seed capital to validate its core proposition: that a medical scribe tailored to hospital-specific templates and integrated into existing EHR workflows can capture meaningful adoption [AI Funding, June 2026].

The business model is a vertical SaaS subscription targeting healthcare organizations, with initial traction reported at over 300 general practices and 14 hospitals [4impact, June 2026]. Over the next 12-18 months, the key indicators to monitor will be the expansion of these early deployments into larger, named hospital systems, the evolution of the platform beyond note transcription into broader workflow automation, and the company's ability to convert its reported usage into sustained, high-value contracts.

Data Accuracy: GREEN -- Key claims on funding, team background, and product positioning are corroborated by multiple independent sources including Caplight, AIPressroom, and AI Funding.

How the Company Got Here

OurMind emerged in 2024 from a founding team of clinicians and engineers in Amsterdam. The company's origin is tied to the professional experience of co-founder Paul Koning, MD, a former orthopedic surgeon who had previously founded and sold a healthtech company [PERPLEXITY SONAR PRO BRIEF]. The founding group started with the stated aim of improving healthcare accessibility and outcomes using generative AI [Sabine Janssen - Huisartsenpraktijk t Zand | LinkedIn, retrieved 2026].

The company developed its core AI documentation platform and secured its first institutional capital in June 2026, a €2.1 million (approximately $2.4 million) early funding round led by 4impact capital [AIPressroom, June 2026] [Caplight, June 2026]. Concurrent with the funding, the company announced its platform was in use by more than 300 general practices and 14 hospitals [4impact, June 2026]. The company also achieved ISO 27001 and NEN 7510 certifications for information security [AI World, June 2026].

Data Accuracy: GREEN -- Founding details and funding round confirmed by multiple independent sources. Customer deployment figures cited by a lead investor.

Product and Technology

OurMind’s core proposition is a generative AI platform designed to function as a digital colleague for healthcare professionals. The platform centers on two primary modules: OurMind Notes, which transcribes physician-patient conversations into structured clinical reports, and OurMind Assistant, which handles letters, referrals, and answers to protocol questions [OurMind]. The company emphasizes deep integration with existing electronic health record (EHR) systems, formatting documentation to hospital-specific templates [OurMind].

The platform supports conversations in over 68 languages and processes audio with a focus on data privacy: audio is deleted immediately after processing and transcripts are automatically removed after 72 hours [OurMind] [AI World, June 2026]. Public certifications include ISO 27001 and the Dutch healthcare-specific NEN 7510 standard [AI World, June 2026]. The go-to-market approach includes a 30-day free trial, and the company has announced plans to offer templates for psychosocial and mental health nurse practitioner consultations [OurMind].

Data Accuracy: GREEN -- Product claims are confirmed by the company website and independent press coverage. Security certifications are specifically cited in a June 2026 news article.

Where the Demand Sits

The market for AI-powered clinical documentation is expanding as a structural response to a healthcare workforce crisis. OurMind operates within the segment of AI medical scribes and clinical workflow automation. For context, the global AI in healthcare market was valued at $15.1 billion in 2022 and is projected to reach $187.95 billion by 2030, growing at a compound annual growth rate (CAGR) of 37% from 2023 to 2030 [Grand View Research, 2023].

Metric	Value
Global AI in Healthcare Market (2022)	$15.1B
Projected Market (2030)	$187.95B
CAGR (2023-2030)	37%

Data Accuracy: YELLOW -- Market sizing figures are from a third-party analyst report for the broader AI in healthcare sector, not specific to clinical documentation.

Competitive Landscape

OurMind enters a crowded field of AI-powered clinical documentation assistants, but its early positioning suggests a deliberate focus on deep, localized integration within the European healthcare system.

Company	Positioning	Stage / Funding	Notable Differentiator
OurMind	AI platform automating clinical documentation and workflows for European healthcare providers.	Seed, ~$2.4M (June 2026)	ISO 27001/NEN 7510 certified; focus on hospital-specific templates and EHR integration in the Netherlands.
Abridge	AI-powered clinical documentation and conversation capture, integrated with major U.S. EHRs.	Series C, $150M+	Strong partnerships with Epic and other large U.S. health systems.
DAX Copilot (Nuance)	Ambient clinical intelligence integrated into Microsoft's ecosystem for healthcare.	Product of Microsoft	Deep integration with Microsoft 365, Teams, and Azure.
DeepScribe	AI medical scribe focused on capturing the natural patient visit.	Series A, $30M+	Emphasis on ambient, non-intrusive capture and specialty-specific workflows.
Suki	Voice-enabled digital assistant for clinicians, specializing in EHR data entry.	Series C, $55M+	Long-standing focus on voice as primary interface.

Data Accuracy: YELLOW -- Competitor funding and positioning are widely reported, but specific differentiation claims for OurMind are based on company materials and a single investor press release.

Opportunity

The opportunity for OurMind is to become the dominant AI-native layer for clinical workflow automation in European healthcare. Paul Koning's prior company, Prisma Network, was acquired by Doctolib, demonstrating founder credibility and a proven ability to build and sell into the complex European healthcare ecosystem [PERPLEXITY SONAR PRO BRIEF]. The company's reported deployment in over 300 general practices and 14 hospitals indicates an early wedge that goes beyond pilot projects [4impact, June 2026].

Data Accuracy: YELLOW -- The core traction metrics are cited by an investor. Growth scenarios are plausible extrapolations based on public product roadmaps and certifications.

Sources

1. [AIPressroom, June 2026] OurMind Raises €2.1M to Streamline Healthcare Admin | https://aipressroom.com/ourmind-2m-healthcare-ai/
2. [AI Funding, June 2026] OurMind Funding & Valuation | https://aifunding.dk/company/ourmind
3. [AI World, June 2026] OurMind Achieves Key Security Certifications | https://aiworld.com/ourmind-security-certifications/
4. [Annals of Internal Medicine, 2016] Allocation of Physician Time in Ambulatory Practice | https://www.acpjournals.org/doi/10.7326/M16-0961
5. [Caplight, June 2026] OurMind | Valuation, Funding Rounds & Stock Price | https://www.caplight.com/company/
6. [Crunchbase] Abridge Company Profile | https://www.crunchbase.com/organization/abridge
7. [Crunchbase] DeepScribe Company Profile | https://www.crunchbase.com/organization/deepscribe
8. [Crunchbase] Suki Company Profile | https://www.crunchbase.com/organization/suki
9. [Djoeri Timessen - Xapo Bank | LinkedIn, retrieved 2026] LinkedIn Post on OurMind's Mission | https://www.linkedin.com/in/djoeri/
10. [Forbes, October 2021] Suki Raises $55 Million to Expand Its AI Assistant for Doctors | https://www.forbes.com/sites/rebeccaszkutak/2021/10/20/suki-raises-55-million-to-expand-its-ai-assistant-for-doctors/
11. [Grand View Research, 2023] Artificial Intelligence In Healthcare Market Size Report, 2023-2030 | https://www.grandviewresearch.com/industry-analysis/artificial-intelligence-ai-healthcare-market
12. [Microsoft] DAX Copilot Product Overview | https://www.microsoft.com/en-us/industry/health/nuance-dax-copilot
13. [OurMind] OurMind Product and Company Website | https://www.ourmind.ai/
14. [Sabine Janssen - Huisartsenpraktijk t Zand | LinkedIn, retrieved 2026] LinkedIn Post on OurMind's Founding | https://www.linkedin.com/in/sabine-janssen-58b782a9/
15. [4impact, June 2026] 4impact Capital Announces Investment in OurMind | https://4impact.capital/news/ourmind-investment